Adult Lymphoma — Trials

Adult Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 17
Ph III recruiting: 2
Growth YoY: —
Industry share: 19%
Top sponsor: City of Hope Medical Center
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 51–83 of 83 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01460940	A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma	completed	Phase 2	24	Ohio State University Comprehensive Cancer CenterOTHER	1	Nov 14, 2017	clinicaltrials
NCT00073918	Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma	completed	Phase 2	111	Fred Hutchinson Cancer CenterOTHER	1	Aug 18, 2017